Human CXCL8 (IL-8)

Avoid repeated freeze-thaw cycles<br>12 months from date of receipt, -20 to -70 °C as supplied.<br>1 month, 2 to 8 °C under sterile conditions after reconstitution.<br>3 months, -20 to -70 °C under sterile conditions after reconstitution.

[interleukin-8; Interleukin-8; interleukin-8; T-cell chemotactic factor; alveolar macrophage chemotactic factor I; beta endothelial cell-derived neutrophil activating peptide; beta-thromboglobulin-like protein; emoctakin; granulocyte chemotactic protein 1; interleukin 8; lung giant cell carcinoma-derived chemotactic protein; lymphocyte derived neutrophil activating peptide; monocyte-derived neutrophil chemotactic factor; monocyte-derived neutrophil-activating peptide; neutrophil-activating peptide 1; small inducible cytokine subfamily B, member 8; tumor necrosis factor-induced gene 1; chemokine (C-X-C motif) ligand 8; MDNCF-c; Neutrophil-activating factor; NAF]